ANURADHA LALA-TRINDADE
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease NEW YORK, NY NPI 1003076902
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease NY Novo Nordisk AS All categories
General Payments — all program years on this page
$280,059.80
- Category: General Payments
- Program years: PY2018–2024
- Record count: 322
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $91,696.49 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $53,142.25 | 15 |
| Honoraria | $23,540.00 | 5 |
| Travel and Lodging | $9,321.21 | 8 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,540.00 | 1 |
| Food and Beverage | $2,153.03 | 38 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $19,438.62 | 6 |
| Boehringer Ingelheim International GmbH | $16,582.65 | 7 |
| Merck Sharp & Dohme Corporation | $13,463.23 | 14 |
| ABIOMED | $10,349.83 | 7 |
| Lexicon Pharmaceuticals, Inc. | $10,164.53 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $5,600.00 | 2 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $5,054.96 | 5 |
| AstraZeneca UK Limited | $4,296.00 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $3,540.00 | 1 |
| Novo Nordisk AS | $2,325.00 | 1 |
| Abbott Laboratories | $664.45 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $68.81 | 3 |
| Acerta Pharma LLC | $48.71 | 2 |
| E.R. Squibb & Sons, L.L.C. | $48.47 | 2 |
| Philips Electronics North America Corporation | $34.24 | 1 |
| PFIZER INC. | $16.99 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.